Matches in SemOpenAlex for { <https://semopenalex.org/work/W4256640087> ?p ?o ?g. }
Showing items 1 to 84 of
84
with 100 items per page.
- W4256640087 endingPage "64" @default.
- W4256640087 startingPage "64" @default.
- W4256640087 abstract "64 Background: Serum adrenal androgen (AA) levels may be prognostic for survival in men with CRPC treated with androgen synthesis inhibitors (ASIs) including ketoconazole (keto) and abiraterone. We hypothesize that up-regulation of the HPAA and adrenocorticotropic hormone (ACTH) may contribute to therapeutic resistance on ASIs. The current study explores the relationship between ACTH, AA, testosterone (T) and estradiol (E) among CRPC patients (pts) treated with ASI + corticosteroids. Methods: Phase 2 study of keto (400 mg TID) + hydrocortisone (HC) (30 mg/day) in pts with CRPC. Pts who achieved ≥ 30% PSA decline from baseline at week 12 continued keto/HC until progression, at which point HC was replaced by dexamethasone (dex). Serum hormone (H) levels were measured (in AM) at baseline and every 4 weeks using standard assays. Statistical tests include Spearman’s rank test for correlation between baseline H levels; Wilcoxon matched pairs for baseline vs. week 4 distribution; and Fisher’s exact test for associations between H levels (dichotomized at median) with PSA decline. Results: Of 30 pts enrolled and 24 evaluable for PSA response, 13 pts (54%) achieved ≥ 30% PSA decline at 12 weeks. Baseline ACTH was positively correlated with DHEA (r = 0.40; p = 0.04) and cortisol (r = 0.52; p = 0.007). Change from baseline to week 4 in H levels is shown in table. There was a significant increase in pts achieving a PSA decline of ≥ 30% if there was a decrease in E at week 4 vs. no decrease (83% vs. 18%; p = 0.003). Baseline and changes in other H levels were not associated with PSA outcome at week 12. Conclusions: ACTH is positively correlated with DHEA and cortisol in CRPC pts. Declines in E may serve as an additional predictive marker of benefit for ASI therapy. These observations require prospective validation. Analyses exploring changes in ACTH at disease progression and impact of substituting dex for HC are ongoing. Clinical trial information: NCT01036594. [Table: see text]" @default.
- W4256640087 created "2022-05-12" @default.
- W4256640087 creator A5001618807 @default.
- W4256640087 creator A5005790201 @default.
- W4256640087 creator A5007578304 @default.
- W4256640087 creator A5012804612 @default.
- W4256640087 creator A5022999202 @default.
- W4256640087 creator A5024203592 @default.
- W4256640087 creator A5024225260 @default.
- W4256640087 creator A5039728792 @default.
- W4256640087 creator A5066372195 @default.
- W4256640087 creator A5073970384 @default.
- W4256640087 creator A5079570071 @default.
- W4256640087 creator A5081123075 @default.
- W4256640087 date "2013-02-20" @default.
- W4256640087 modified "2023-10-18" @default.
- W4256640087 title "Evaluating the hypothalamic-pituitary-adrenal axis (HPAA) in men receiving ketoconazole for castrate-resistant prostate cancer (CRPC)." @default.
- W4256640087 doi "https://doi.org/10.1200/jco.2013.31.6_suppl.64" @default.
- W4256640087 hasPublicationYear "2013" @default.
- W4256640087 type Work @default.
- W4256640087 citedByCount "0" @default.
- W4256640087 crossrefType "journal-article" @default.
- W4256640087 hasAuthorship W4256640087A5001618807 @default.
- W4256640087 hasAuthorship W4256640087A5005790201 @default.
- W4256640087 hasAuthorship W4256640087A5007578304 @default.
- W4256640087 hasAuthorship W4256640087A5012804612 @default.
- W4256640087 hasAuthorship W4256640087A5022999202 @default.
- W4256640087 hasAuthorship W4256640087A5024203592 @default.
- W4256640087 hasAuthorship W4256640087A5024225260 @default.
- W4256640087 hasAuthorship W4256640087A5039728792 @default.
- W4256640087 hasAuthorship W4256640087A5066372195 @default.
- W4256640087 hasAuthorship W4256640087A5073970384 @default.
- W4256640087 hasAuthorship W4256640087A5079570071 @default.
- W4256640087 hasAuthorship W4256640087A5081123075 @default.
- W4256640087 hasConcept C121608353 @default.
- W4256640087 hasConcept C126322002 @default.
- W4256640087 hasConcept C126894567 @default.
- W4256640087 hasConcept C134018914 @default.
- W4256640087 hasConcept C16005928 @default.
- W4256640087 hasConcept C2777911890 @default.
- W4256640087 hasConcept C2779279991 @default.
- W4256640087 hasConcept C2779548794 @default.
- W4256640087 hasConcept C2780192828 @default.
- W4256640087 hasConcept C2780401358 @default.
- W4256640087 hasConcept C2780455818 @default.
- W4256640087 hasConcept C2780546910 @default.
- W4256640087 hasConcept C2781064554 @default.
- W4256640087 hasConcept C71315377 @default.
- W4256640087 hasConcept C71924100 @default.
- W4256640087 hasConceptScore W4256640087C121608353 @default.
- W4256640087 hasConceptScore W4256640087C126322002 @default.
- W4256640087 hasConceptScore W4256640087C126894567 @default.
- W4256640087 hasConceptScore W4256640087C134018914 @default.
- W4256640087 hasConceptScore W4256640087C16005928 @default.
- W4256640087 hasConceptScore W4256640087C2777911890 @default.
- W4256640087 hasConceptScore W4256640087C2779279991 @default.
- W4256640087 hasConceptScore W4256640087C2779548794 @default.
- W4256640087 hasConceptScore W4256640087C2780192828 @default.
- W4256640087 hasConceptScore W4256640087C2780401358 @default.
- W4256640087 hasConceptScore W4256640087C2780455818 @default.
- W4256640087 hasConceptScore W4256640087C2780546910 @default.
- W4256640087 hasConceptScore W4256640087C2781064554 @default.
- W4256640087 hasConceptScore W4256640087C71315377 @default.
- W4256640087 hasConceptScore W4256640087C71924100 @default.
- W4256640087 hasIssue "6_suppl" @default.
- W4256640087 hasLocation W42566400871 @default.
- W4256640087 hasOpenAccess W4256640087 @default.
- W4256640087 hasPrimaryLocation W42566400871 @default.
- W4256640087 hasRelatedWork W1976035881 @default.
- W4256640087 hasRelatedWork W1977493149 @default.
- W4256640087 hasRelatedWork W1979452793 @default.
- W4256640087 hasRelatedWork W1981433740 @default.
- W4256640087 hasRelatedWork W1986311037 @default.
- W4256640087 hasRelatedWork W2037816029 @default.
- W4256640087 hasRelatedWork W2053247908 @default.
- W4256640087 hasRelatedWork W2083564258 @default.
- W4256640087 hasRelatedWork W2089368232 @default.
- W4256640087 hasRelatedWork W2170790420 @default.
- W4256640087 hasVolume "31" @default.
- W4256640087 isParatext "false" @default.
- W4256640087 isRetracted "false" @default.
- W4256640087 workType "article" @default.